Epitestosterone is the 17-alpha isomer of testosterone, derived from pregnenolone via the delta5-steroid pathway, and via 5-androstene-3-beta,17-alpha-diol. Epitestosterone acts as an antiandrogen in various target tissues. The ratio between testosterone/epitestosterone is used to monitor anabolic drug abuse.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Flunisolide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Flunisolide. |
| Beclomethasone dipropionate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Beclomethasone dipropionate. |
| Betamethasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Betamethasone. |
| Fluticasone propionate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocinolone acetonide. |
| Triamcinolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Triamcinolone. |
| Prednisone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisone. |
| Fludrocortisone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fludrocortisone. |
| Hydrocortisone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone. |
| Prednisolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisolone. |
| Methylprednisolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Methylprednisolone. |
| Trilostane | The risk or severity of edema formation can be increased when Epitestosterone is combined with Trilostane. |
| Budesonide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Budesonide. |
| Dexamethasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Dexamethasone. |
| Corticotropin | The risk or severity of edema formation can be increased when Epitestosterone is combined with Corticotropin. |
| Cortisone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Cortisone acetate. |
| Paramethasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Paramethasone. |
| Ciclesonide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Ciclesonide. |
| Aldosterone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Aldosterone. |
| Fluticasone furoate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluticasone furoate. |
| Fluprednidene | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluprednidene. |
| Tixocortol | The risk or severity of edema formation can be increased when Epitestosterone is combined with Tixocortol. |
| Fluprednisolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluprednisolone. |
| Meprednisone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Meprednisone. |
| Dexamethasone isonicotinate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Dexamethasone isonicotinate. |
| Melengestrol | The risk or severity of edema formation can be increased when Epitestosterone is combined with Melengestrol. |
| Deflazacort | The risk or severity of edema formation can be increased when Epitestosterone is combined with Deflazacort. |
| Cortivazol | The risk or severity of edema formation can be increased when Epitestosterone is combined with Cortivazol. |
| Prednylidene | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednylidene. |
| Fluocortin | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocortin. |
| Fluperolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluperolone. |
| Cloprednol | The risk or severity of edema formation can be increased when Epitestosterone is combined with Cloprednol. |
| Fluclorolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluclorolone. |
| Fluticasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluticasone. |
| Mometasone furoate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Mometasone furoate. |
| Hydrocortisone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone acetate. |
| Hydrocortisone cypionate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone cypionate. |
| Hydrocortisone succinate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone succinate. |
| Prednisolone phosphate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisolone phosphate. |
| Prednisolone hemisuccinate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisolone hemisuccinate. |
| Methylprednisolone hemisuccinate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Methylprednisolone hemisuccinate. |
| Prednisone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisone acetate. |
| Clocortolone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Clocortolone acetate. |
| Melengestrol acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Melengestrol acetate. |
| Betamethasone phosphate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Betamethasone phosphate. |
| Cortisone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Cortisone. |
| Clobetasol propionate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Clobetasol propionate. |
| Fluocinonide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocinonide. |
| Hydrocortisone butyrate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone butyrate. |
| Desoximetasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Desoximetasone. |
| Mometasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Mometasone. |
| Fluocortolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocortolone. |
| Prednisolone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisolone acetate. |
| Fluorometholone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluorometholone. |
| Difluocortolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Difluocortolone. |
| Flumethasone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Flumethasone. |
| Methylprednisolone aceponate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Methylprednisolone aceponate. |
| Dexamethasone acetate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Dexamethasone acetate. |
| Corticotropin zinc hydroxide | The risk or severity of edema formation can be increased when Epitestosterone is combined with Corticotropin zinc hydroxide. |
| Fluocortolone pivalate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocortolone pivalate. |
| Fluocortolone caproate | The risk or severity of edema formation can be increased when Epitestosterone is combined with Fluocortolone caproate. |
| Desoxycortone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Desoxycortone. |
| Vamorolone | The risk or severity of edema formation can be increased when Epitestosterone is combined with Vamorolone. |